Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Learn the right situations to adopt monthly budgeting and practical steps to implement it effectively in your financial routine.
18,733 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
PVH stock plunged today after a warning about a downturn in a top international segment. This article breaks down the...
SpaceX publicly reframes its business as AI services and infrastructure, a move that could redefine growth prospects ...
Bitcoin steadies near $60,000 as Pi Network’s PI token rebounds after hitting a new all-time low. Weekend liquidity a...
As the fourth quarter wrapped up, foreclosure auctions surged last, signaling rising distress in several markets. Thi...
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
OpenAI confronts multi-front pressure as its largest backer rethinks bets, Microsoft shifts workloads inward, and riv...
Mortgage lenders are navigating a regulatory minefield as AI-generated marketing enters the mortgage space. New rules...
With the Social Security trust fund projected to run dry by the early 2030s, Congress faces a high-stakes fight over ...
Bark is shaping its path in a competitive pet market. This guide breaks down what to expect in bark (bark) 2026 earni...
Elon Musk’s focus on memory capacity reshapes the outlook for micron, sandisk, hynix investors as AI-driven demand te...
Rocket Lab isn’t profitable yet, but the space company shows four clear catalysts for investors. Here are practical r...